Regulatory News New FDA mandate to tell patients whether their breasts are “dense” or “not dense” baffles doctorsProblem: “Breast density is in the eye of the mammographer” September 27, 2024Vol.50 No.36By Claire Marie Porter
Regulatory News ODAC votes overwhelmingly in support of PD-L1 expression as predictive biomarker for efficacy of checkpoint inhibitorsVote applies across drugs and indications September 27, 2024Vol.50 No.36By Jacquelyn Cobb
PubMed’s failure to display all papers by authors who publish under multiple names “mistreats women,” lawsuit contends September 27, 2024Vol.50 No.36By Jacquelyn Cobb
Cancer History ProjectGuest Editorial How First Lady Betty Ford and surgeon Bernie Fisher revolutionized America’s attitude toward breast cancer September 27, 2024Vol.50 No.36By Stacy Wentworth
FreeIn the Archives Jose and Irma Russo— husband and wife trailblazers in breast cancer research September 27, 2024Vol.50 No.36
Regulatory News Melanoma investigators invite FDA to publicly discuss approval endpoints and crossover designThe agency accepts the invitation September 20, 2024Vol.50 No.35By Paul Goldberg
Guest Editorial Group chairs propose funding strategy to jump-start correlative studies September 20, 2024Vol.50 No.35By Peter J. O'Dwyer
AACR progress report highlights AI’s role in research and clinical careObstacles to progress include systemic disparities and dwindling appropriations September 20, 2024Vol.50 No.35By McKenzie Prillaman
Mace Rothenberg’s museum will tell the stories behind breakthroughs in medicine September 20, 2024Vol.50 No.35By McKenzie Prillaman
2024 Lasker Awards honor discoveries in antitumor immunity, GLP-1-based drugs, and research, advocacy in HIV/AIDS September 20, 2024Vol.50 No.35By Claire Marie Porter
